Literature DB >> 15626584

Oesophageal bioadhesion of sodium alginate suspensions 2. Suspension behaviour on oesophageal mucosa.

J Craig Richardson1, Peter W Dettmar, Frank C Hampson, Colin D Melia.   

Abstract

Sodium alginate suspensions in a range of water miscible vehicles were investigated as novel bioadhesive liquids for targeting the oesophageal mucosa. Such a dosage form might be utilised to coat the oesophageal surface and provide a protective barrier against gastric reflux, or to deliver therapeutic agents site-specifically. Alginate suspensions swelled and formed an adherent viscous layer on contact with the mucosa. The swelling kinetics of alginate particles on the oesophageal surface was examined with respect to vehicle composition and related to the extent, duration and location of bioadhesion within the oesophagus. Mucosal retention was evaluated in two in vitro models utilising tissue immersion and a peristaltic tube. By varying the vehicle composition it was possible to modulate the rate of swelling of alginate particles on the mucosa and the mucosal retention of suspensions. Suspensions containing predominantly glycerol exhibited superior retention and were preferentially retained within the lower oesophagus. The propensity of these suspensions to rapidly swell on the mucosa and establish adhesive/cohesive bonds may explain their enhanced retention. The potential to control, through vehicle composition, the extent, duration and location of oesophageal retention could provide a useful tool for site targeting of viscous polymers to the oesophagus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15626584     DOI: 10.1016/j.ejps.2004.10.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  4 in total

1.  Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model.

Authors:  Roberta Salaroli; Domenico Ventrella; Chiara Bernardini; Alberto Elmi; Augusta Zannoni; Maria Laura Bacci; Monica Forni; Fiorella Calanni; Antonella Ferrieri; Fabio Baldi
Journal:  Clin Exp Gastroenterol       Date:  2020-11-13

2.  Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model.

Authors:  Massimo P Di Simone; Fabio Baldi; Valentina Vasina; Fabrizio Scorrano; Maria Laura Bacci; Antonella Ferrieri; Gilberto Poggioli
Journal:  Clin Exp Gastroenterol       Date:  2012-06-11

3.  A novel ex vivo porcine model of acid-induced esophageal damage for preliminary functional evaluations of anti-gastroesophageal reflux disease medical devices.

Authors:  Domenico Ventrella; Roberta Salaroli; Alberto Elmi; Giacomo Carnevali; Monica Forni; Fabio Baldi; Maria Laura Bacci
Journal:  Vet World       Date:  2020-12-21

4.  Cyclodextrin Polymer Preserves Sirolimus Activity and Local Persistence for Antifibrotic Delivery over the Time Course of Wound Healing.

Authors:  Nathan A Rohner; Steve J Schomisch; Jeffrey M Marks; Horst A von Recum
Journal:  Mol Pharm       Date:  2019-02-26       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.